Journey Medical (DERM) presented data assessing the dermal and systemic pharmacokinetics of oral DFD-29 versus oral Doxycycline 40 mg capsules in healthy subjects at the 44th Fall Clinical ...

"This NDA submission is a significant milestone for Journey Medical and we look forward to collaborating with the FDA during its review to bring DFD-29, a potentially differentiated, best-in-class ...

Additionally, DFD-29 treatment did not cause significant proliferation of opportunistic organisms, negative impact on normal microbial floral or bacterial resistance over the course of 16 weeks ...

The Canadian Cancer Society’s Relay for Life was held in Oakville at Appleby College in 2013. Participants camped on the field, and walked the track around the campus from 7 p.m.-7 a.m., after the ...